Log in

CTTH CTT Pharmaceutical Holdings, Inc. OTC · United States

CTT Pharmaceutical Holdings (CTTH) news

Top story · Oct 9, 2026 · SEC filing 8-K

CTT Pharmaceutical changes its auditor

Source: 8-K filed Oct 9, 2026 on SEC EDGAR

Latest CTT Pharmaceutical Holdings news

We have not published a story on CTT Pharmaceutical Holdings yet. When there is news, it will appear here.

CTT Pharmaceutical Holdings annual financials

LineFY2014FY2013
Net income (loss)-$672,162-$18,911
Cash from operations-$72,250-$209
Cash and equivalents$81,179$0
Short-term investments$0

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $31.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about CTT Pharmaceutical Holdings

What is the ticker symbol of CTT Pharmaceutical Holdings?

CTT Pharmaceutical Holdings, Inc. trades under the ticker CTTH on OTC.

Where is CTT Pharmaceutical Holdings listed?

CTT Pharmaceutical Holdings, Inc. is listed on OTC.

What is the SEC CIK of CTT Pharmaceutical Holdings?

The SEC Central Index Key (CIK) for CTT Pharmaceutical Holdings, Inc. is 1035422. Its filings are on SEC EDGAR.

How many shares does CTT Pharmaceutical Holdings have outstanding?

59,722,232 shares as of 2026-09-11, per the cover page of its 10-Q filed 2026-09-17.

Which country or territory is CTT Pharmaceutical Holdings listed under?

Our directory records CTT Pharmaceutical Holdings, Inc. under United States.

What does CTT Pharmaceutical Holdings do?

Our directory classifies CTT Pharmaceutical Holdings, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of CTT Pharmaceutical Holdings?

The ISIN recorded for CTT Pharmaceutical Holdings, Inc. is US12651E1064.

Does aibio.space cover CTT Pharmaceutical Holdings?

aibio.space lists CTT Pharmaceutical Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is CTT Pharmaceutical Holdings incorporated?

SEC records list its state or country of incorporation as FL.

Is CTT Pharmaceutical Holdings profitable?

CTT Pharmaceutical Holdings, Inc. reported a net loss of $672,162 for the fiscal year ended Dec 31, 2014, and used $72,250 of cash in operations, per its annual report to the SEC.

How much cash does CTT Pharmaceutical Holdings have?

$31 in cash at Jun 30, 2026, per its 10-Q.

Is CTT Pharmaceutical Holdings a smaller reporting company?

SEC records list CTT Pharmaceutical Holdings, Inc.'s filer category as: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company.

Where is CTT Pharmaceutical Holdings headquartered?

SEC records list its business address as 1646 W. SNOW AVE SUITE 138, TAMPA, FL, 33606.

When does CTT Pharmaceutical Holdings's fiscal year end?

CTT Pharmaceutical Holdings, Inc.'s fiscal year ends on December 31, per SEC records.

What did CTT Pharmaceutical Holdings last file with the SEC?

Its most recent filing in our record is an 8-K filed 2026-10-09. All of its filings are on SEC EDGAR. Source.

Investor discussion: CTT Pharmaceutical Holdings

Members talk about CTT Pharmaceutical Holdings (CTTH). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at CTT Pharmaceutical Holdings, newest first. Each line links the filing it comes from.

  1. Legal

    Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:CTTH on TradingView.

SEC filings and registration

SEC name
Ctt Pharmaceutical Holdings, Inc.
CIK
1035422
Industry (SIC)
Pharmaceutical Preparations (2834)
US tickers
CTTH (OTC)
State or country of incorporation
FL
Fiscal year ends
December 31
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Business address
1646 W. SNOW AVE SUITE 138, TAMPA, FL, 33606
Phone
813-606-0060
Shares outstanding
59,722,232 as of 2026-09-11 (10-Q filed 2026-09-17)
Former names
Mindesta Inc.; INDUSTRIAL MINERALS INC; PNW CAPITAL INC

Recent filings (8-K and 6-K are the company's own announcements)

  • 8-K filed 2026-10-09
  • 8-K filed 2026-10-07
  • 8-K filed 2026-09-23
  • 10-Q filed 2026-09-17
  • 8-K filed 2026-08-12
  • S-1 filed 2025-12-30
  • 8-K filed 2016-02-11
  • 10-Q filed 2015-11-23

Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

Listing details

CTT Pharmaceutical Holdings, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker CTTH, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
CTT Pharmaceutical Holdings, Inc.
Ticker
CTTH
Listing
OTC
Country or territory
United States
Business scope
Pharmaceuticals: Major
ISIN
US12651E1064
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.